Skip to main content
Top

24-10-2017 | Breast cancer | Article

Addition of T2-guided optical tomography improves noncontrast breast magnetic resonance imaging diagnosis

Journal: Breast Cancer Research

Authors: Jinchao Feng, Junqing Xu, Shudong Jiang, Hong Yin, Yan Zhao, Jiang Gui, Ke Wang, Xiuhua Lv, Fang Ren, Brian W. Pogue, Keith D. Paulsen

Publisher: BioMed Central

Abstract

Background

While dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) is recognized as the most sensitive examination for breast cancer detection, it has a substantial false positive rate and gadolinium (Gd) contrast agents are not universally well tolerated. As a result, alternatives to diagnosing breast cancer based on endogenous contrast are of growing interest. In this study, endogenous near-infrared spectral tomography (NIRST) guided by T2 MRI was evaluated to explore whether the combined imaging modality, which does not require contrast injection or involve ionizing radiation, can achieve acceptable diagnostic performance.

Methods

Twenty-four subjects—16 with pathologically confirmed malignancy and 8 with benign abnormalities—were simultaneously imaged with MRI and NIRST prior to definitive pathological diagnosis. MRIs were evaluated independently by three breast radiologists blinded to the pathological results. Optical image reconstructions were constrained by grayscale values in the T2 MRI. MRI and NIRST images were used, alone and in combination, to estimate the diagnostic performance of the data. Outcomes were compared to DCE results.

Results

Sensitivity, specificity, accuracy, and area under the curve (AUC) of noncontrast MRI when combined with T2-guided NIRST were 94%, 100%, 96%, and 0.95, respectively, whereas these values were 94%, 63%, 88%, and 0.81 for DCE MRI alone, and 88%, 88%, 88%, and 0.94 when DCE-guided NIRST was added.

Conclusion

In this study, the overall accuracy of imaging diagnosis improved to 96% when T2-guided NIRST was added to noncontrast MRI alone, relative to 88% for DCE MRI, suggesting that similar or better diagnostic accuracy can be achieved without requiring a contrast agent.
Literature
1.
Schnall MD. Application of magnetic resonance imaging to early detection of breast cancer. Breast Cancer Res. 2001;3(1):17–21.CrossRefPubMed
2.
Warner E, Plewes DB, Shumak RS, Catzavelos GC, Di Prospero LS, Yaffe MJ, et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol. 2001;19(15):3524–31.CrossRefPubMed
3.
Constance DL, Jeffrey DB, Paul W, David T, Nola H, Ellen W, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer. 2005;103(9):1898–905.CrossRef
4.
Lehman CD, Gatsonis C, Kuhl CK, Hendrick RE, Pisano ED, Hanna L, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356(13):1295–303.CrossRefPubMed
5.
Lord SJ, Lei W, Craft P, Cawson JN, Morris I, Walleser S, et al. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer. 2007;43(13):1905–17.CrossRefPubMed
6.
Rahul DT, Melanie C, Lisa AR, Alice R, Ashwin K, Roger M, et al. Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation. Cancer. 2009;115(8):1621–30.CrossRef
7.
Ulrich B. Intensified surveillance for early detection of breast cancer in high-risk patients. Breast Care. 2015;10:13–20.CrossRef
8.
Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology. 2001;220(1):13–30.CrossRefPubMed
9.
Bartella L, Smith CS, Dershaw DD, Liberman L. Imaging breast cancer. Radiol Clin N Am. 2007;45:45–67.CrossRefPubMed
10.
Sibel K, Şukru O, İlker E, Özlem K. Can unenhanced breast MRI be used to decrease negative biopsy rates? Diagn Interv Radiol. 2015;21(4):287–92.CrossRef
11.
Trimboli RM, Verardi N, Cartia F, Carbonaro LA, Sardanelli F. Breast cancer detection using double reading of unenhanced MRI including T1-weighted, T2-weighted STIR, and diffusion-weighted imaging: a proof of concept study. AJR Am J Roentgenol. 2014;203(3):674–81.CrossRefPubMed
12.
Segal AJ, Bush WH. Avoidable errors in dealing with anaphylactoid reactions to iodinated contrast media. Invest Radiol. 2011;46:147–51.CrossRefPubMed
13.
Boncher AN, Vricella GJ, Smith M, Passalacqua M, Gulani V, Ponsky LE. Contrast-induced nephropathy and nephrogenic systemic fibrosis: minimizing the risk. Can J Urol. 2012;19:6074–80.
14.
FDA Drug Safety Communication. New warnings for using gadolinium-based contrast agents in patients with kidney dysfunction. US Food and Drug Administration. http://​www.​fda.​gov/​Drugs/​DrugSafety/​ucm223966.​htm. Published 9 September 2010. Updated 1 May 2010. Accessed 13 Aug 2016.
15.
FDA Drug Safety Communication. FDA evaluating the risk of brain deposits with repeated use of gadolinium-based contrast agents for magnetic resonance imaging (MRI). US Food and Drug Administration. http://​www.​fda.​gov/​Drugs/​DrugSafety/​ucm455386.​htm. Published 27 July 2015. Accessed 13 Aug 2016.
16.
Baltzer PA, Benndorf M, Dietzel M, Gajda M, Camara O, Kaise WA. Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions. Eur Radiol. 2010;20:1101–10.CrossRefPubMed
17.
Yabuuchi H, Matsuo Y, Sunami S, Kamitani T, Kawanami S, Setoguchi T, et al. Detection of non-palpable breast cancer in asymptomatic women by using unenhanced diffusion-weighted and T2-weighted MR imaging: comparison with mammography and dynamic contrast-enhanced MR imaging. Eur Radiol. 2011;21:11–7.CrossRefPubMed
18.
Kuroki-Suzuki S, Kuroki Y, Nasu K, Nawano S, Moriyama N, Okazaki M. Detecting breast cancer with non-contrast MR imaging: combining diffusion-weighted and STIR imaging. Magn Reson Med Sci. 2007;6:21–7.CrossRefPubMed
19.
Parsian S, Rahbar H, Allison KH, Demartini WB, Olson ML, Lehman CD, et al. Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging. Radiology. 2012;265:696–706.CrossRefPubMedPubMedCentral
20.
Mastanduno MA, El-Ghussein F, Jiang S, Diflorio-Alexander R, Junqing X, Hong Y, et al. Adaptable near-infrared spectroscopy fiber array for improved coupling to different breast sizes during clinical MRI. Acad Radiol. 2014;21(2):141–50.CrossRefPubMedPubMedCentral
21.
Carpenter CM, Pogue BW, Jiang S, Dehghani H, Wang X, Paulsen KD, et al. Image-guided optical spectroscopy provides molecular-specific information in vivo: MRI-guided spectroscopy of breast cancer hemoglobin, water, and scatterer size. Opt Lett. 2007;32(8):933–5.CrossRefPubMed
22.
Ntziachristos V, Chance B. Breast imaging technology: probing physiology and molecular function using optical imaging-applications to breast cancer. Breast Cancer Res. 2001;3(1):41–6.CrossRefPubMed
23.
Boas DA, Brooks DH, Miller EL, DiMarzio CA, Kilmer M, Gaudette RJ, et al. Imaging the body with diffuse optical tomography. IEEE Signal Process Mag. 2001;18(6):57–75.CrossRef
24.
Jiang S, Pogue BW, Kaufman PA, Gui J, Jermyn M, Frazee TE, et al. Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment. Clin Cancer Res. 2014;20(23):6006–15.CrossRefPubMedPubMedCentral
25.
Zhu Q, Ricci A, Hegde P, Kane M, Cronin E, Merkulov A, et al. Assessment of functional differences in malignant and benign breast lesions and improvement of diagnostic accuracy by using US-guided diffuse optical tomography in conjunction with conventional US. Radiology. 2016;280(2):387–97.CrossRefPubMedPubMedCentral
26.
Zhao Y, Mastanduno MA, Jiang S, El-Ghussein F, Gui J, Pogue BW, et al. Optimization of image reconstruction for magnetic resonance imaging-guided near-infrared diffuse optical spectroscopy in breast. J Biomed Opt. 2015;20(5):056009.CrossRefPubMedCentral
27.
Fang Q, Selb J, Carp S, Boverman G, Miller EL, Brooks DH, et al. Combined optical and X-ray tomosynthesis breast imaging. Radiology. 2011;258(1):89–97.CrossRefPubMedPubMedCentral
28.
Ntziachristos V, Yodh AG, Schnall M, Chance B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci. 2000;97(6):2767–72.CrossRefPubMedPubMedCentral
29.
Brooksby B, Pogue BW, Jiang S, Dehghani H, Srinivasan S, Kogel C, et al. Imaging breast adipose and fibroglandular tissue molecular signatures by using hybrid MRI-guided near-infrared spectral tomography. Proc Natl Acad Sci. 2005;103(23):8828–33.CrossRef
30.
Mastanduno MA, Xu J, El-Ghussein F, Jiang S, Yin H, Zhao Y, et al. Sensitivity of MRI-guided near-infrared spectroscopy clinical breast exam data and its impact on diagnostic performance. Biomed Opt Express. 2014;5(9):3103–15.CrossRefPubMedPubMedCentral
31.
Mastanduno M, Xu J, El-Ghussein F, Jiang S, Yin H, Zhao Y, et al. MR-guided near-infrared spectral tomography increases diagnostic performance of breast MRI. Clin Cancer Res. 2015;21(17):3906–12.CrossRefPubMedPubMedCentral
32.
Teifke A, Lehr HA, Vomweg TW, Hlawatsch A, Thelen M. Outcome analysis and rational management of enhancing lesions incidentally detected on contrast-enhanced MRI of the breast. Am J Roentgenol. 2003;181:655–62.CrossRef
33.
Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology. 1999;211:101–10.CrossRefPubMed
34.
Dehghani H, Eames ME, Yalavarthy PK, Davis SC, Srinivasan S, Carpenter CM, et al. Near infrared optical tomography using NIRFAST: algorithm for numerical model and image reconstruction. Commun Numer Methods Eng. 2009;25(6):711–32.CrossRef
35.
Zhang L, Zhao Y, Jiang S, Pogue BW, Paulsen KD. Direct regularization from co-registered anatomical images for MRI-guided near-infrared spectral tomographic image reconstruction. Biomed Opt Express. 2015;6(9):3618–30.CrossRefPubMedPubMedCentral
36.
Feng J, Jiang S, Zhao Y, Xu J, Davis SC, Pogue BW, et al. Direct soft prior regularization in NIR spectral tomography from MRI-contrast and distance-constraints, for segmentation-free reconstruction. Biomedical Optics 2016, paper JM3A.4.
37.
Telegrafo M, Rella L, Stabile AI, Angelelli G, Moschetta M. Unenhanced breast MRI (STIR, T2-weighted TSE, DWIBS): an accurate and alternative strategy for detecting and differentiating breast lesions. Magn Reson Imaging. 2015;33(8):951–5.CrossRefPubMed
38.
Shin HJ, Chae EY, Choi WJ, Ha SM, Park JY, Shin KC, et al. Diagnostic performance of fused diffusion-weighted imaging using unenhanced or postcontrast T1-weighted MR imaging in patients with breast cancer. Medicine. 2016;95(17):e3502.CrossRefPubMedPubMedCentral